NCT02259738View on ClinicalTrials.gov

Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Cerebral Infarction
Interventions
DRUG

Human Urinary Kallidinogenase

DRUG

Shuxuening injection

Trial Locations (1)

100053

Department of Neurolgy,Xuanwu Hospital of Capital Medical University, Beijing

All Listed Sponsors
lead

XuanwuH 2

OTHER

NCT02259738 - Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase | Biotech Hunter | Biotech Hunter